DSM Sinochem Pharmaceuticals (DSP), the global leader in sustainable antibiotics, next generation statins and anti-fungals. We develop, produce and sell generic intermediates, active pharmaceutical ingredients (API) and drug products (DP).

Our employees worldwide work together to deliver cutting edge generics solutions that help to keep customers ahead of the competition.

 

Headquartered in Singapore, we have manufacturing sites and sales offices in China, India, Egypt, the Netherlands, Spain, the USA and Mexico.

News

12 June, 2018

Mr. Feng Zhibin, Chairman of the Board of DSM Sinochem Pharmaceuticals, has resigned from his position as Vice President of Sinochem Group.

Read more

9 May, 2018

Joint  Workshop in Thailand by DSM Sinochem Pharmaceuticals and Indian Institute of Technology, New Delhi on Sustainable Manufacturing of Pharmaceuticals

Read more

26 April, 2018

DSM Sinochem Pharamaceuticals successfully hosts STEM workshop in Manila Philippines

Read more

12 April, 2018

Call on Dutch health insurers: ‘Choose sustainably in the battle against antibiotic resistance’

Read more

23 April, 2018

Successful CPIA visit to DSP site Delft

Read more

Copyright © 2017 DSM Sinochem Pharmaceuticals

Join the conversation

Follow us on Facebook Follow us on Twitter Follow us on LinkedIn
Sustainable Antibiotics: our PureActives API are sustainable enzymatic antibiotics.
Sustainable Antibiotics: our PureActives API are sustainable enzymatic antibiotics.
Follow us on Facebook Follow us on Twitter Follow us on LinkedIn
Sustainable Antibiotics: our PureActives API are sustainable enzymatic antibiotics.
Sustainable Antibiotics: our PureActives API are sustainable enzymatic antibiotics.
Sustainable Antibiotics: our PureActives API are sustainable enzymatic antibiotics.
Sustainable Antibiotics: our PureActives API are sustainable enzymatic antibiotics.
Sustainable Antibiotics: our PureActives API are sustainable enzymatic antibiotics.
DSM Sinochem Pharmaceuticals logo
Sustainable Antibiotics: our PureActives API are sustainable enzymatic antibiotics.